Takeda
Associate Director, Global Health Economics Lead, Oncology Business Unit
Takeda, Bridgeport, Connecticut, us, 06610
Overview
Associate Director, Global Health Economics Lead, Oncology Business Unit This role offers a base pay range of
$153,600.00/yr - $241,340.00/yr . The actual pay will be based on skills and experience; speak with your recruiter to learn more. Responsibilities
Drive value demonstration strategies for Health Technology Appraisal (HTA; including the EU Joint Clinical Assessment [JCA]) and payer assessments to optimize rapid, broad patient access, achieve value-based prices and lead performance in line with commercial objectives Lead health economics (HE) plans and outline strategic approaches to drive pricing and reimbursement activities. Conduct hands-on economic assessments for oncology medicines at all stages of development, using HE models and materials including systematic literature reviews (SLRs), indirect treatment comparisons (ITCs), statistical analyses of trial and real-world data and other methods as appropriate Oversee country roll-out and training on global HE materials and provide country response to payer inquiries. Lead the development and country adaptations of HTA models with regional and local operating company (LOC) Market Access and HE leads Lead and develop robust publication plans to drive access to portfolio medicines through HTA assessments and life cycle management Global Value Proposition: establish understanding of burden of disease, unmet need and appropriate comparator; co-lead with Market Access the development of the global value proposition to ensure a compelling value story for payers; identify and prioritize strategic opportunities to enhance and expand product value proposition for new indications Evidence Generation: drive planning to provide clinical, economic and humanistic value to HTA bodies and payers; coordinate across functions to ensure evidence needs are incorporated into Global, Regional and Local initiatives Evaluate HTA outcomes and implications for value positioning and evidence requirements; shape the product’s evidence generation plan; make recommendations on additional data generation based on payer and HTA needs Lead the integration of payer-relevant HE endpoints in the clinical development plan HE and Value & Access Tools: develop state-of-the-art HE models and studies (e.g., SLRs, ITCs) with robust evidentiary support; train Regions and LOCs on value platforms, new evidence and HE studies and models Co-lead with Pricing & Market Access the conceptualization of value-based contract (VBC) options, develop VBC toolkits and assess their commercial impact Support development/updating of the product value platform (Value Story, Global Value Dossiers, Objection Handler, Access Solutions Toolkit and Global Pricing Guidance) Market Access: proactively address payer, HTA and policymaker demands; respond to market opportunities/challenges in coordination with regional/local PVA Leads; stay aware of evolving HTA and reimbursement landscape Communication/Publication: ensure the drug’s value proposition is recognized by external stakeholders to maximize market access and uptake; translate HE messages for manuscripts, posters and publications; develop payer-focused materials Develop and manage collaborations with HE key opinion leaders, academic researchers and vendors to stay up to date on HE methods Lead Role of Takeda Oncology HE projects accountable to Head, Global Health Economics & US HEOR; scope to lead with LOCs globally in value demonstration and HTA via HE modelling and related studies Remit includes all in-market brands and development molecules Prepare for and participate in global HTA submissions and related activities Qualifications
Minimum Qualifications/Requirements: Advanced Degree (PhD or Master’s) in Health Economics, Economics, Medicine, Pharmacy, Public Health, Health Services Research or related field 6 to 8 years of relevant experience in healthcare industry with direct experience in global product value proposition development and interaction with payers, HTA bodies and policymakers; strong patient-centered focus Robust understanding of the global payer environment and ex-US payer landscape including HTA trends (e.g., NICE, CADTH, PBAC, EU JCA) and US Medicare (Part D), ICER; knowledge of Emerging Markets reimbursement issues Strong knowledge and hands-on experience in health economics, HTA tools, SLRs, ITCs, statistical analyses and economic modelling Understanding of clinical and epidemiological information, global pricing models, and analyses of large databases; knowledge of Outcomes Research (PROs, modelling) Leadership in a highly matrixed organization; strong analytical, communication and strategic/problem-solving skills Influencing skills and ability to translate technical issues to non-technical audiences Preferred: experience in Hematology/Oncology; global and US HTA knowledge; direct payer experience; track record of peer-reviewed publications Travel: 5 to 10% domestic and/or international travel may be required About Takeda
Takeda is a patient-focused global biopharmaceutical company transforming patient care with a commitment to Better Health and a Brighter Future. Hybrid work policy applies; compensation and benefits vary by location. This posting includes a U.S. base salary range; actual compensation depends on qualifications and location. EEO: Takeda is committed to creating a diverse workforce and providing equal employment opportunities to all applicants. Work Details
Locations: United States (Remote/Hybrid as applicable) Worker Type: Employee Worker Sub-Type: Regular Time Type: Full time
#J-18808-Ljbffr
Associate Director, Global Health Economics Lead, Oncology Business Unit This role offers a base pay range of
$153,600.00/yr - $241,340.00/yr . The actual pay will be based on skills and experience; speak with your recruiter to learn more. Responsibilities
Drive value demonstration strategies for Health Technology Appraisal (HTA; including the EU Joint Clinical Assessment [JCA]) and payer assessments to optimize rapid, broad patient access, achieve value-based prices and lead performance in line with commercial objectives Lead health economics (HE) plans and outline strategic approaches to drive pricing and reimbursement activities. Conduct hands-on economic assessments for oncology medicines at all stages of development, using HE models and materials including systematic literature reviews (SLRs), indirect treatment comparisons (ITCs), statistical analyses of trial and real-world data and other methods as appropriate Oversee country roll-out and training on global HE materials and provide country response to payer inquiries. Lead the development and country adaptations of HTA models with regional and local operating company (LOC) Market Access and HE leads Lead and develop robust publication plans to drive access to portfolio medicines through HTA assessments and life cycle management Global Value Proposition: establish understanding of burden of disease, unmet need and appropriate comparator; co-lead with Market Access the development of the global value proposition to ensure a compelling value story for payers; identify and prioritize strategic opportunities to enhance and expand product value proposition for new indications Evidence Generation: drive planning to provide clinical, economic and humanistic value to HTA bodies and payers; coordinate across functions to ensure evidence needs are incorporated into Global, Regional and Local initiatives Evaluate HTA outcomes and implications for value positioning and evidence requirements; shape the product’s evidence generation plan; make recommendations on additional data generation based on payer and HTA needs Lead the integration of payer-relevant HE endpoints in the clinical development plan HE and Value & Access Tools: develop state-of-the-art HE models and studies (e.g., SLRs, ITCs) with robust evidentiary support; train Regions and LOCs on value platforms, new evidence and HE studies and models Co-lead with Pricing & Market Access the conceptualization of value-based contract (VBC) options, develop VBC toolkits and assess their commercial impact Support development/updating of the product value platform (Value Story, Global Value Dossiers, Objection Handler, Access Solutions Toolkit and Global Pricing Guidance) Market Access: proactively address payer, HTA and policymaker demands; respond to market opportunities/challenges in coordination with regional/local PVA Leads; stay aware of evolving HTA and reimbursement landscape Communication/Publication: ensure the drug’s value proposition is recognized by external stakeholders to maximize market access and uptake; translate HE messages for manuscripts, posters and publications; develop payer-focused materials Develop and manage collaborations with HE key opinion leaders, academic researchers and vendors to stay up to date on HE methods Lead Role of Takeda Oncology HE projects accountable to Head, Global Health Economics & US HEOR; scope to lead with LOCs globally in value demonstration and HTA via HE modelling and related studies Remit includes all in-market brands and development molecules Prepare for and participate in global HTA submissions and related activities Qualifications
Minimum Qualifications/Requirements: Advanced Degree (PhD or Master’s) in Health Economics, Economics, Medicine, Pharmacy, Public Health, Health Services Research or related field 6 to 8 years of relevant experience in healthcare industry with direct experience in global product value proposition development and interaction with payers, HTA bodies and policymakers; strong patient-centered focus Robust understanding of the global payer environment and ex-US payer landscape including HTA trends (e.g., NICE, CADTH, PBAC, EU JCA) and US Medicare (Part D), ICER; knowledge of Emerging Markets reimbursement issues Strong knowledge and hands-on experience in health economics, HTA tools, SLRs, ITCs, statistical analyses and economic modelling Understanding of clinical and epidemiological information, global pricing models, and analyses of large databases; knowledge of Outcomes Research (PROs, modelling) Leadership in a highly matrixed organization; strong analytical, communication and strategic/problem-solving skills Influencing skills and ability to translate technical issues to non-technical audiences Preferred: experience in Hematology/Oncology; global and US HTA knowledge; direct payer experience; track record of peer-reviewed publications Travel: 5 to 10% domestic and/or international travel may be required About Takeda
Takeda is a patient-focused global biopharmaceutical company transforming patient care with a commitment to Better Health and a Brighter Future. Hybrid work policy applies; compensation and benefits vary by location. This posting includes a U.S. base salary range; actual compensation depends on qualifications and location. EEO: Takeda is committed to creating a diverse workforce and providing equal employment opportunities to all applicants. Work Details
Locations: United States (Remote/Hybrid as applicable) Worker Type: Employee Worker Sub-Type: Regular Time Type: Full time
#J-18808-Ljbffr